PIN42 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients: A Post-Hoc Analysis of Il-28B Subgroup

The Cost ◽

Post Hoc ◽

1102 THE COST-EFFECTIVENESS OF TELAPREVIR (TVR) IN COMBINATION WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PR) FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS

Journal of Hepatology ◽

10.1016/s0168-8278(12)61114-3 ◽

2012 ◽

Vol 56 ◽

pp. S434 ◽

Cited By ~ 3

Author(s):

S. Curtis ◽

S. Cure ◽

S. Gavart ◽

L. Dearden ◽

J. Fleischmann ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

The Cost ◽

PIN27 The Cost-Effectiveness of Telaprevir (TVR) in Combination With Pegylated Interferon-Alfa and Ribavirin (PR) for the Treatment of Genotype 1(G1) Chronic Hepatitis C Patients

Value in Health ◽

10.1016/j.jval.2012.03.1303 ◽

2012 ◽

Vol 15 (4) ◽

pp. A241-A242

Author(s):

S. Cure ◽

S. Curtis ◽

F. Bianic ◽

S. Gavart ◽

L. Dearden ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

The Cost ◽

PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS)

Value in Health ◽

10.1016/j.jval.2011.08.236 ◽

2011 ◽

Vol 14 (7) ◽

pp. A274 ◽

Cited By ~ 1

Author(s):

E. Nikoglou ◽

S. Humphreys ◽

A. El khoury ◽

S.A. Ferrante ◽

C. O' Regan

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

National Health Service ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Trial Analysis ◽

24 Weeks Treatment with Pegylated Interferon Alfa Plus Ribavirin May Be Possible in Genotype 1 Chronic Hepatitis C Patients with Rapid Virological Response Who Have Low Pretreatment Viremia

Korean Journal of Gastroenterology ◽

10.4166/kjg.2010.56.1.33 ◽

2010 ◽

Vol 56 (1) ◽

pp. 33 ◽

Cited By ~ 3

Author(s):

Sung Soo Moon ◽

Hyoun Gu Kang ◽

Jeong Ah Seo ◽

Eun Uk Jung ◽

Sang Heon Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Rapid Virological Response ◽

Genotype 1 ◽

838 Pegylated Interferon Alfa, Nitazoxanide, Telapravir, Ribavirin, in Genotype 1 Undergoing Prior Experienced Chronic Hepatitis C Patients-a Randomized Placebo Control Clinical Pilot Trial (I N T R I G U E C) Interim

Gastroenterology ◽

10.1016/s0016-5085(12)63615-4 ◽

2012 ◽

Vol 142 (5) ◽

pp. S-932 ◽

Cited By ~ 1

Author(s):

Patrick Basu ◽

Thankam Nair ◽

Sakina Farhat ◽

Sajith Foustin ◽

Lynn P. Ang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pilot Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Placebo Control ◽

Genotype 1 ◽

Pegylated Interferon Alfa, Nitazoxanide, Telaprevir, Ribavirin, in Genotype 1 Undergoing Prior Experienced Chronic Hepatitis C Patients - A Randomized Placebo Control Clinical Pilot Trial (INTRIGUE-C)

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-00363 ◽

2012 ◽

Vol 107 ◽

pp. S154

Author(s):

Patrick Basu ◽

N. Shah ◽

S. Farhat ◽

R. Siriki ◽

Md Rahman ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pilot Trial ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Placebo Control ◽

Genotype 1 ◽

PGI18 Cost-Effectiveness of Boceprevir in Combination With Pegylated Interferon Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C: Submission to the National Institute for Health and Clinical Excellence (NICE)

Value in Health ◽

10.1016/j.jval.2012.08.767 ◽

2012 ◽

Vol 15 (7) ◽

pp. A328-A329 ◽

Cited By ~ 1

Author(s):

S.C. Humphreys ◽

E.H. Elbasha ◽

S.A. Ferrante ◽

M. Lion ◽

C. O'Regan

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Clinical Excellence ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Pegylated Interferon Alfa

Su1030 Genetic Variation in Vitamin D Pathway DHCR7 Gene Predicts Poor Response to Pegylated Interferon-Alfa Based Therapy in Asian Chronic Hepatitis C Genotype 1-Infected Patients

Gastroenterology ◽

10.1016/s0016-5085(14)63521-6 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-967

Author(s):

Kessarin Thanapirom ◽

Sirinporn Suksawatamnuay ◽

Wattana Sukeepaisarnjaroen ◽

Pisit Tangkijvanich ◽

Panarat Thaimai ◽

...

Keyword(s):

Vitamin D ◽

Genetic Variation ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Poor Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 1 ◽

Pegylated Interferon Alfa

335 Interim results of a randomized trial of 1.5μG/ KG vs. 3.0 μG/KG pegylated interferon alfa 2-B PEG-intron(R) (PEG) plus ribavirin (RBV) for naïve chronic hepatitis C patients and 3.0μG/KG PEG plus RBV for non-responders (NR) and relapsers (R) to previous therapy. (The target trial)

Hepatology ◽

10.1016/s0270-9139(03)80378-6 ◽

2003 ◽

Vol 38 ◽

pp. 321-321

Author(s):

C WHITE ◽

P MALET ◽

C WENTWORTH ◽

V CANTU ◽

T ALTON ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Randomized Trial ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Target Trial ◽

Previous Therapy ◽

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program

Journal of Hepatology ◽

10.1016/j.jhep.2010.06.038 ◽

2011 ◽

Vol 54 (2) ◽

pp. 227-235 ◽

Cited By ~ 14

Author(s):

Thierry Poynard ◽

Mona Munteanu ◽

Massimo Colombo ◽

Jordi Bruix ◽

Eugene Schiff ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Independent Predictor ◽

Pegylated Interferon ◽

Virologic Response ◽

Interferon Alfa ◽